Original Keyword,Processed Keyword
UCHL1,
&#945,
(Acute respiratory distress syndrome) ARDS,ALI/ARDS
(Cyclin-dependent kinase inhibitor 1B),
?B),
"0.9% saline, angiopoietin 2, P-selectin",
17 beta-estradiol,
1-antitrypsin,
2-chlorofatty acid,
"3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)",
34-1-2S,
4-dihydroxyphenyl)-2-hydroxypropanoate,
A549,
Abl2,
Acacetin,
ACE,ACE/ACE2
ACE2,ACE/ACE2
ACE-2,ACE/ACE2
ACE-2 receptor,
Acid aspiration,
acidic microenvironment,
acidosis,
acrolein,
actin,
actin cytoskeleton,
Acute aortic dissection,acute aortic dissection
acute aortic dissection,
acute chest syndrome,
Acute ethanol intoxication,
acute inflammation of lung injury,
Acute kidney injury,
acute king injury,Acute kidney injury
acute lung,
Acute lung inflammation,
Acute lung injury,ALI/ARDS
acute lung injury,ALI/ARDS
Acute Lung Injury,ALI/ARDS
Acute lung injury (ALI),ALI/ARDS
acute lung injury (ALI),ALI/ARDS
acute lung injury and acute respiratory distress syndrome,ALI/ARDS
acute pancreatitis,
Acute pancreatitis,acute pancreatitis
Acute pulmonary endothelial cell injury,
Acute respiratory distress syndrome,ALI/ARDS
Acute Respiratory Distress Syndrome,ALI/ARDS
acute respiratory distress syndrome,ALI/ARDS
Acute respiratory distress syndrome (ARDS),ALI/ARDS
acute respiratory distress syndrome (ARDS),ALI/ARDS
acute respiratory distress syndrome/acute lung injury (ARDS/ALI),ALI/ARDS
acute respiratory distress syndromes and acute lung injury,ALI/ARDS
ADAM10,
"adenosine 3 ',5 '-cyclic monophosphate",
adherence,
Adherens junction,adhesion junction
adherens junction,adhesion junction
adherens junctions,adhesion junction
adherens junctions (AJs),adhesion junction
Adhesion,
adhesion junction,
adhesion molecule,adhesion molecules
Adhesion molecules,adhesion molecules
adhesion molecules,
adipokine,
Adipose stromal cells,
adipose tissue-derived stem cell,
adipose-derived exosomes,
Adipose-derived mesenchymal stem cells,
Adipose-derived stem cells,
adrenomedullin,
ADSCs exosome,
Adult stem cells,
aerobic glycolysis,
AFM,
aging,
airway diseases,
airway epithelium,
airway inflammation,
Akt,Akt/Akt1
AKT,Akt/Akt1
Akt pathway,Akt/Akt1
Akt signaling pathway,Akt/Akt1
Akt/GSK-3 beta,AKT/GSK3 beta signaling pathway
AKT/GSK3 beta signaling pathway,
Akt/mTOR signal pathway,
AKT1,Akt/Akt1
Akt1,Akt/Akt1
albumin,
Alda-1,
aldehyde dehydrogenase,ALDH/ALDH2
aldehyde dehydrogenase 2 (ALDH2),ALDH/ALDH2
ALDH2,ALDH/ALDH2
ALI,ALI/ARDS
ALI/ARDS,ALI/ARDS
Alk5,
allogeneic bone marrow transplantation,
alpha(2)-Adrenoceptor,alpha(2)-adrenoreceptor
alpha(2)-adrenoreceptor,
alpinetin,
alternative methods,
alveolar capillary dysplasia,
alveolar collapse,
alveolar epithelial cell (AEC),alveolar epithelial cells
alveolar epithelial cells,
Alveolar epithelial cells,alveolar epithelial cells
alveolar epithelial fluid transport,
alveolar fluid clearance,
Alveolar macrophages,alveolar macrophages
alveolar macrophages,
alveolar permeability,
alveolar remodeling,
Alveolar type II epithelial cell,
amiloride-insensitive sodium channel,
AMP-activated protein kinase,AMPK
AMPK,
anagliptin,
and mouth disease,
ANDV,
angiogenesis,
Angiogenesis,angiogenesis
angiopoietin,angiopoietin-1/angiopoietin-2
angiopoietin (Ang)-1 &-2,angiopoietin-1/angiopoietin-2
angiopoietin 2,angiopoietin-1/angiopoietin-2
angiopoietin-1,angiopoietin-1/angiopoietin-2
Angiopoietin-1,angiopoietin-1/angiopoietin-2
Angiopoietin-1 and-2,angiopoietin-1/angiopoietin-2
Angiopoietin-1 gene,angiopoietin-1/angiopoietin-2
angiopoietin-2,angiopoietin-1/angiopoietin-2
Angiopoietin-2,angiopoietin-1/angiopoietin-2
angiopoietin-like protein 4,
Angiopoietins,angiopoietin-1/angiopoietin-2
angiotensin,angiotensin
Angiotensin converting enzyme,ACE/ACE2
Angiotensin converting enzyme 2 (ACE2),ACE/ACE2
angiotensin II,angiotensin
Angiotensin II,angiotensin
angiotensin II receptors,angiotensin
angiotensin-(1-7),angiotensin
angiotensin-(1-7) receptor blocker,angiotensin
angiotensin-converting enzyme,ACE/ACE2
angiotensin-converting enzyme 2,ACE/ACE2
Animal models,
anti-apoptosis,
Antibodies,
anticoagulants,
antiinflammation,Anti-inflammation
Anti-inflammation,
Anti-inflammatory therapy,Anti-inflammation
antioxidant,
Antioxidant enzyme mimetic,
Antioxidant response element,
Antioxidant therapy,
antiplatelet,
Antiplatelet agents,antiplatelet
Aortic dissection,
apelin-13,
Apelin-13,apelin-13
Apelin-APJ axis,
Apolipoprotein A-I,
Apolipoprotein E,
APOM,
Apoptosis,apoptosis
apoptosis,
AQP1,aquaporin 1
aquaporin 1,
aquaporin-1,aquaporin 1
Aquaporins,
ARDS,ALI/ARDS
ARDS/ALI,ALI/ARDS
Arg,Arginine
arginase 1,
Arp 2/3,
artificial sweeteners,artificial sweetener
aspirin,
asthma,
Astilbin,
asymmetric dimethylarginine,
ATG16L1,
atherosclerosis,
Atrial natriuretic peptide,
aureus),
autophagy,
Autophagy,autophagy
AUY-922,
B cell colony-enhancing factor,
bacterial DNA,
bacterial infection,
bacterial lipopolysaccharide,
BALF,
BAP31,
barrier disruption,
Barrier dysfunction,barrier dysfunction
barrier dysfunction,
barrier function,
Barrier function,barrier function
barrier permeability,permeability
Barrier permeability,permeability
barrier protection,
Barrier regulation,
Basic science,
basic science research,
Bcl-2,
beas-2b,
Beclin-1,
Berberine,berberine
berberine,
beta 1 integrin,
Beta-arrestin-1 penehyclidine hydrochloride,
beta-NAD,
bicarbonate,
bindarit,
biomarker,biomarkers
Biomarker,biomarkers
biomarkers,
Biomarkers,biomarkers
Bioprocessing,
bitter taste receptors,
Blebbistatin,
Bleomycin,
blood-air barrier hyperpermeability,hyperpermeability
Blood-borne cells,
blood-brain barrier,
BLT1,
BLT2,
BML-111,
BMP signaling in endothelial cells,
BMP9,
Bone morphogenetic protein,bone morphogenetic proteins
bone morphogenetic proteins,
bovine serum albumin nanoparticles,
bradykinin,
brain injury,
bronchiectasis,
Bronchoalveolar lavage (BAL),BALF
bronchoalveolar lavage fluid,BALF
bronchopulmonar dysplasia,bronchopulmonary dysplasia
bronchopulmonary dysplasia,
Btk,
Burn,burn
burn,
burns,burn
C16,
C23,
C3a,
C3a-C3aR,
C3G,
C5a,
C5aR1 inhibition,
Ca2+,
c-Abl,c-Abl
C-Abl,c-Abl
c-abl gene,c-Abl
c-Abl tyrosine kinase,c-Abl
Cadherin,cadherin
cadherin,
Calcineurin/NFATc3,
calcitonin gene-related peptide,
Calcium,calcium
calcium,
calcium channels,
Calcium signal,
Calpain,
cAMP,
cancer,
capillary endothelial permeability,permeability
capillary leak,
Capillary permeability,permeability
Capillary Permeability,permeability
captopril,
carboxyl stress,
Cardamonin,
cardiopulmonary bypass,
CARDS,ALI/ARDS
caspase 3,caspase-1/caspase-3/caspase-11
caspase-1,caspase-1/caspase-3/caspase-11
Caspase-1,caspase-1/caspase-3/caspase-11
Caspase-11,caspase-1/caspase-3/caspase-11
caspase-11,caspase-1/caspase-3/caspase-11
caspase-3,caspase-1/caspase-3/caspase-11
CaSR,
catalase,
catenin,
cathepsin B,
Cathepsin G,
cationic polymers,cationic polymer
Cav-1,caveolin-1
caveolae,caveolin-1
caveolae (caveolin-1),caveolin-1
caveolin-1,
Caveolin-1,caveolin-1
CCL2,
CCL-2,CCL2
CCL25,
CCR11,
CD163,
CD200-CD200R,
CD26,
CD31,
CD40L,
CD41,
CD54,
Cdc42,
cdc42-deficient,
CDH5,
Cdk2,
CDKN1B,
Celigo,
cell adhesion,
Cell apoptosis,
cell biology,
cell culture,
cell culture model for lung transplantation,
Cell cultures,
Cell cytoskeleton,
Cell damage,
cell junction,
cell mechanics,
cell migration,
cell permeability,permeability
Cell proliferation,
Cell signalling,
Cell survival,
cell therapy,
Cell therapy,cell therapy
cell transformation,
cell transmigration,
Cell transplantation,
cell-derived extracellular vesicles,
cell-free microRNAs,
cells,
Cellular adhesion molecules,
Cellular bioenergetics,
Ceramide,
Chaperone heat shock protein 90,
chemokine,chemokines
chemokine receptors,
chemokines,
Chemokines,chemokines
chemotaxis,
cholin transporter-like protein 2,
chronic bronchitis,
chronic obstructive pulmonary disease,chronic obstructive pulmonary disease (COPD)
chronic obstructive pulmonary disease (COPD),
chronic rhinosinusitis,
cigarette smoke,
Ciliary arteries,
Circ_0054633,
circEXOC5,
circKlhl2,
circPalm2,
circulating endothelial cells,ECs/HPMECs/HUVECs/MPVECs
Circulating endothelial cells,ECs/HPMECs/HUVECs/MPVECs
Circulatory extracellular vesicles,
circWDR33,
CIRP,
Cisatracurium,
citrullinated histone H3,
citrulline,
C-Jun,
CLASP2,
Class IIA HDACs inhibition,
clathrin-mediated endocytosis,
claudin,claudins
Claudin-18,
Claudin5,claudin-5
Claudin-5,claudin-5
claudin-5,
claudins,
Clinical trial,
Clinical trials,Clinical trial
clodronate,
clopidogrel,
CLP,
CLP sepsis,
CO2-removal,
coagulation,
Coagulation,coagulation
coagulation endothelial cell,coagulation
coagulation/fibrinolysis,coagulation
coagulopathy,coagulation
co-culture,
cofilin-1,
co-inhibitory receptor,
collapse,
Community-acquired pneumonia,
compartmentalization,
compartmentalized cAMP,
complement,
Complement,complement
complement activation,
concentration-sensitive sodium channel,
Connexin40,
connexins,
COPD,chronic obstructive pulmonary disease (COPD)
Cordyceps militaris (CM),
coronavirus,COVID-19/SARS-CoV-2/Coronavirus
coronavirus disease 2019,COVID-19/SARS-CoV-2/Coronavirus
cortactin,
Cortactin,cortactin
cortical actin,
CoV-2,
COVID acute respiratory distress syndrome,COVID-19/SARS-CoV-2/Coronavirus
COVID-19,COVID-19/SARS-CoV-2/Coronavirus
COVID-19 complications,COVID-19/SARS-CoV-2/Coronavirus
COVID-19 disease,COVID-19/SARS-CoV-2/Coronavirus
COVID-19 murine model,COVID-19/SARS-CoV-2/Coronavirus
COVID-19 pro-inflammatory cytokines,COVID-19/SARS-CoV-2/Coronavirus
Coxsackievirus A2,
CpG DNA,
cre/loxp,
Cre/Loxp technique,cre/loxp
critical care,
Crocin,
crosstalk,
c-Src,
C-terminal binding protein 2 (CTBP2),
C-type natriuretic peptide,
curcumin,
C-X3-C motif chemokine ligand 1,
CX3CL1-CX3CR1 axis,
Cx40,Connexin40
CXC chemokines,
cxcl3,
CXCR2,
CXCR3,
cyclase,
Cyclic AMP,cAMP
cyclic stretch,
CYP1B1,
cystic fibrosis,
Cytochrome P450,
cytokine,cytokines
Cytokine,cytokines
cytokine release syndrome,
cytokine storm,
Cytokine storm,cytokine storm
Cytokines,cytokines
cytokines,
Cytoprotection,
cytoskeletal dynamics,
cytoskeletal rearrangement,
Cytoskeleton,cytoskeleton
cytoskeleton,
DAD,
Damage -associated molecular patterns,DAMPs
Damage-associated molecular patterns,DAMPs
DAMP,DAMPs
DAMPs,
danger-associated molecular pattern,DAMPs
dauricine,
decursin,
Decursinol angelate,
Dehydrozingerone,
Desialylation,
DEX,dexamethasone
dexamethasone,
Dexamethasone,dexamethasone
Dexamethasone delivery,
Dexamethasone nanoparticles,
dexmedetomidine,
diagnosis,
diannexin,
Differentiation,
diffuse alveolar damage score,
dimethylarginine dimethylaminohydrolase II,
Diosmetin,
Dipeptidyl peptidase 4,dipeptidyl peptidase-4
dipeptidyl peptidase-4,
Direct lung injury,
disseminated intravascular coagulation (DIC),
disseminated intravascular microthrombosis (DIT),
DJ-1,
DNA methylation,
DNA repair,
Donor variability,
DPP4,dipeptidyl peptidase-4
DPP4 inhibitor,
drug delivery,
Drug delivery,drug delivery
drug targeting,
Dual-Specificity Phosphatases,
DUSP4,
dysfunction,
eCIRP,
ECIS,
edaravone,
Edema,
edema,
EGFR,
Elastance,
Elastase,
electric cell-substrate impedance sensing,
electron microscopy,
ELISA,
ELK3,
embryonic development,
emphysema,
Endocan,
endocytosis,
endoglin (Eng),
EndoMT,
endoplasmic reticulum-plasma membrane junctions,
endosome,
endothelial,ECs/HPMECs/HUVECs/MPVECs
Endothelial,ECs/HPMECs/HUVECs/MPVECs
endothelial activation,
endothelial adhesion molecules,
endothelial Barrier,ECs/HPMECs/HUVECs/MPVECs
endothelial barrier,ECs/HPMECs/HUVECs/MPVECs
Endothelial barrier,ECs/HPMECs/HUVECs/MPVECs
Endothelial barrier dysfunction,endothelial barrier dysfunction
endothelial barrier dysfunction,
Endothelial barrier function,endothelial barrier function
endothelial barrier function,
Endothelial Barrier function,endothelial barrier function
endothelial barrier regulation,
Endothelial barrier regulation,
endothelial barrier restoration,
endothelial biology,
endothelial cell,ECs/HPMECs/HUVECs/MPVECs
Endothelial cell,ECs/HPMECs/HUVECs/MPVECs
Endothelial cell (EC),ECs/HPMECs/HUVECs/MPVECs
endothelial cell barrier,ECs/HPMECs/HUVECs/MPVECs
endothelial cell barrier dysfunction,endothelial barrier dysfunction
endothelial cell dysfunction,endothelial dysfunction
Endothelial cell inflammation,
Endothelial cell injury,Endothelial damage
endothelial cells,ECs/HPMECs/HUVECs/MPVECs
Endothelial cells,ECs/HPMECs/HUVECs/MPVECs
endothelial cells (EC),ECs/HPMECs/HUVECs/MPVECs
endothelial cells (ECs),ECs/HPMECs/HUVECs/MPVECs
Endothelial cells-derived exosome,
Endothelial damage,
Endothelial dysfunction,endothelial dysfunction
endothelial dysfunction,
Endothelial glycocalyx,endothelial glycocalyx (EG)
endothelial glycocalyx,endothelial glycocalyx (EG)
endothelial glycocalyx (EG),
endothelial growth response 2,
endothelial hyperpermeability,hyperpermeability
Endothelial mesenchymal transition,
endothelial microparticles,
endothelial niche,
endothelial nitric oxide synthase,eNOS
Endothelial nitric oxide synthase,eNOS
endothelial nitric oxide synthase uncoupling,eNOS
endothelial permeability,permeability
Endothelial permeability,permeability
Endothelial progenitor cells,endothelial progenitor cells
endothelial progenitor cells,
endothelial pyroptosis,
endothelial regeneration,
endothelial repair,
Endothelial targeting,
endothelial wound healing,
endothelial-barrier function,
endothelialization,
endothelial-to-mesenchymal transition,
Endothelial-to-mesenchymal transition,endothelial-to-mesenchymal transition
endotheliitis,
Endotheliitis,endotheliitis
endotheliopathy,
endotheliopathy-associated vascular microthrombotic disease (EA-VMTD),
endothelium,ECs/HPMECs/HUVECs/MPVECs
Endothelium,ECs/HPMECs/HUVECs/MPVECs
endothelium cells,ECs/HPMECs/HUVECs/MPVECs
Endotoxemia,endotoxemia
endotoxemia,
endotoxic shock,
Endotoxin,endotoxin
endotoxin,
eNOS,eNOS
eNOS pathway,eNOS
eNOS uncoupling,eNOS
enrichment analysis,
Enzymology,
EOMA,
Epac,
Epac1,
EPCR,
epigenetic modifiers,
epigenetics,
epithelial cell,
Epithelial sodium channel,epithelial sodium channel
epithelial sodium channel,
epithelial-endothelial barrier,
epithelial-mesenchymal transition (EMT),
epithelium,
ER stress,ERS
ERK,ERK/ERK1/ERK2
ERK1/2,ERK/ERK1/ERK2
ERKs,ERK/ERK1/ERK2
ERM,
ERR alpha,
ERS,
erythropoietin,
E-selectin,
E-selectin-binding peptide,E-selectin-binding peptides
E-selectin-binding peptides,
eukaryotic elongation factor 2,
evans blue,
ex vivo ventilation perfusion,
EX527,
exchange factor directly activated by cyclic adenosine monophosphate,
exercise immunology,
exocytosis,
exosome,exosomes
Exosome,exosomes
exosomes,
Exosomes,exosomes
eXpress Permeability Test (XPerT),
expression profile,
EXT-1,
Extracellular histones,extracellular histones
extracellular histones,
extracellular matrix,
extracellular signal-regulated kinase,ERK/ERK1/ERK2
extracellular vesicle,extracellular vesicles (EVs)
extracellular vesicles,extracellular vesicles (EVs)
extracellular vesicles (EVs),
Extracellular vesicles (EVs),extracellular vesicles (EVs)
extracellular-regulated kinase,ERK/ERK1/ERK2
extravasated platelet aggregation (EPA),
Ezrin,
Ezrin protein,Ezrin
Ezrin/radixin/moesin,ERM
F-actin,
Factor associated suicide,
factor Xa,
FAK,Focal adhesion kinase (FAK)
Fas,
Fas ligand,Fas
Fasudil,fasudil
fasudil,
fat embolism syndrome,
Fatty acid synthase,
febrile-range hyperthermia,
ferroptosis,
Ferroptosis,ferroptosis
Ferulic acid,
FGF2,
FGF5,
FGFR1,
Fibrin,fibrin
fibrin,
fibrinogen,
fibrinolysis,
fibroblasts,
fibrosis,
FK-866,
flash photolysis,
flavin-containing monooxygenase,
flow cytometry,
Flow cytometry,flow cytometry
flowmotion,
Fluids,
focal adhesion,
focal adhesion complexes,
focal adhesion kinase,Focal adhesion kinase (FAK)
Focal adhesion kinase (FAK),
follistatin-like protein 1,
foot,
forkhead box O1 (FOXO1),FoxO/FoxO1
forkhead transcription factor O1,FoxO/FoxO1
FOXF1,
FoxM1,
FoxO,FoxO/FoxO1
Free radicals,
FTY720,
FTY720 S-phosphonate,
functional genomics,
fusion to endothelium,
G protein-couple receptors,
G(+)-toxins,
G2A receptor,
GAB1,
Gadolinium chloride,
Galectin,
Gap junction,gap junctions
gap junctions,
gasdermin D (GSDMD),
Gastric acid aspiration,
GEF-H1,
gene delivery,
Gene therapy,gene therapy
gene therapy,
genistein-3 '-sodium sulphonate,
Ghrelin,
Ginsenoside Rb1,
glucocorticoids,
glucose metabolism,
glycocalyx,endothelial glycocalyx (EG)
Glycocalyx,endothelial glycocalyx (EG)
Glycocalyx damage,
Glycolysis,
gp91phox-/-,
GPIIb/IIIa antagonists,
G-protein coupled receptor,
GPX4,
group V soluble phospholipase A(2) inflammation,
Growth arrest-specific gene 6 (Gas6),
Growth hormone-releasing hormone,
GSK2798745,
GSK-3beta,
GSTpi,
GTPase,
guanine nucleotide exchange factors,
gVPLA(2),
gypenosides,
H+ exchanger,
H2AX,
haloperidol,
hand,
hantavirus,
HCl,
HDAC5,
HDAC6,histone deacetylase 6
HDL dysfunction,
Heart,
heat shock protein,
heat shock protein 27,
Heat shock protein A12B,
heat stress,
Heat stress,heat stress
heatstroke,
Hedgehog signal pathway,
heme,
heme oxygenase-1,HO-1
Heme oxygenase-1,HO-1
Heme Oxygenase-1 (HO-1),HO-1
hemin,
hemocompatibility,
hemoglobin,
hemopexin,
hemorrhage,
hemorrhagic shock,
Hemorrhagic shock,hemorrhagic shock
hemostatic disorder,
heparanase,
Heparanase,heparanase
Heparanase (HPA),heparanase
heparin,
Heparin,heparin
heparinase,heparanase
heparin-binding protein (HBP),
Hepatic growth factor,
Hepatocyte growth factor,hepatocyte growth factor (HGF)
hepatocyte growth factor,hepatocyte growth factor (HGF)
hepatocyte growth factor (HGF),
heterogeneity,
heterogeneous nuclear ribonucleoprotein A1,
HIF1 alpha,HIF/HIF1 alpha
HIF-1 alpha,HIF/HIF1 alpha
HIF1A,HIF/HIF1 alpha
high mobility group 1,HMGB1
High mobility group box 1,HMGB1
high mobility group box 1,HMGB1
High mobility group box protein 1,HMGB1
high mobility group box-1,HMGB1
high throughput satellite,
hirudin,
Hirudin,hirudin
histone acetylation,
histone deacetylase,
histone deacetylase 6,
histone deacetylase 6 (HDAC6),histone deacetylase 6
histone deacetylase inhibitors,
histone deacetylases,histone deacetylase
Histones,histones
histones,
HLA,
HLA class I,HLA
HMGB1,
HMGB1/TLR-4,
HMVEC,ECs/HPMECs/HUVECs/MPVECs
HMVECs,ECs/HPMECs/HUVECs/MPVECs
HNA,
HO-1,
host defense peptides,host defense peptide
HOXB4,
HPA,heparanase
hpaec,ECs/HPMECs/HUVECs/MPVECs
HPMEC,ECs/HPMECs/HUVECs/MPVECs
HPMECs,ECs/HPMECs/HUVECs/MPVECs
HPMEC-ST1.6R,ECs/HPMECs/HUVECs/MPVECs
HPMVEC,ECs/HPMECs/HUVECs/MPVECs
HSF1,
Hsp27,
Hsp70,
HSP90 inhibition,
HSPA12A,
HSPA12B,
HTS,
human,
Human leukocyte antigen-A2,
Human lung,
Human lung epithelial cell,
human lung microvascular endothelial cell,ECs/HPMECs/HUVECs/MPVECs
Human lung microvascular endothelial cell,ECs/HPMECs/HUVECs/MPVECs
Human lung microvascular endothelial cells,ECs/HPMECs/HUVECs/MPVECs
Human microvascular endothelial cells (HMEC),ECs/HPMECs/HUVECs/MPVECs
human neutrophil antigens,HNA
Human pulmonary microvascular,
Human pulmonary microvascular endothelial,ECs/HPMECs/HUVECs/MPVECs
human pulmonary microvascular endothelial cell,ECs/HPMECs/HUVECs/MPVECs
Human pulmonary microvascular endothelial cell,ECs/HPMECs/HUVECs/MPVECs
human pulmonary microvascular endothelial cells,ECs/HPMECs/HUVECs/MPVECs
Human pulmonary microvascular endothelial cells,ECs/HPMECs/HUVECs/MPVECs
human pulmonary microvascular endothelial cells (HPMECs),ECs/HPMECs/HUVECs/MPVECs
human tissue factor pathway inhibitor (hTFPI),
human toxicology,
human umbilical cord mesenchymal stem cell,
HuR,
HUVEC,ECs/HPMECs/HUVECs/MPVECs
HUVECs,ECs/HPMECs/HUVECs/MPVECs
Hyaline membranes,
Hyaluronan,
Hyaluronic,
hydrochloric acid,
hydrogen peroxide,
Hydrogen sulfide,hydrogen sulfide
hydrogen sulfide,
Hydrogen-rich medium,
Hydrolyzing angiotensin II (AngII),
hypercapnia,
hypercapnic acidosis,
Hypercoagulopathy,
hyperinflation,
hyperoxia,
Hyperoxia,hyperoxia
hyperoxia induced acute lung injury,hyperoxia; ALI/ARDS
hyperoxic acute lung injury,hyperoxia; ALI/ARDS
hyperpermeability,
Hyper-permeability,hyperpermeability
hyperthermia,
hypertonic saline,
hypoxemia,
hypoxia,
Hypoxia inducible factor-1 alpha,HIF/HIF1 alpha
hypoxia-inducible factor,HIF/HIF1 alpha
hypoxia-inducible factor 1 alpha,HIF/HIF1 alpha
hypoxic pulmonary vasoconstriction,
ICAM1,ICAM-1
ICAM-1,
IFN gamma,
IFN regulatory factor 1,
IGFBP7,
IL-10,interleukin-10
IL-6,interleukin-6
IL-8,interleukin-8
image cytometry,
Imatinib,imatinib
imatinib,
immune complex,
Immune response,immune response
immune response,
Immunity,
Immunoassay,
immunohistochemistry,
Immunology and Microbiology Section,
Immunomodulation,
immunopositive cells,immunopositive cell
Immunothrombosis,immunothrombosis
immunothrombosis,
In silico study,
in vitro disease modeling,
in vivo lung perfusion,
inactive rhomboid-like protein 2,
Indinavir,
indirect acute lung injury,ALI/ARDS
indirect ARDS,ALI/ARDS
Indirect lung injury,ALI/ARDS
Induced pluripotent stem cell,induced pluripotent stem cell
induced pluripotent stem cell,
induced pluripotent stem cells,induced pluripotent stem cell
infection,
inflammasome,
Inflammasome activation,
Inflammation,
inflammation,Inflammation
inflammatory,Inflammation
inflammatory cytokines,
Inflammatory cytokines,inflammatory cytokines
inflammatory disease,Inflammation
inflammatory immune response,
Inflammatory injury,Inflammation
inflammatory mediator,
Inflammatory regulation,
inflammatory response,
Inflammatory response,inflammatory response
Inflammatory responses,inflammatory response
inflammatory signaling,
influenza,
Influenza,influenza
Influenza virus,influenza
inhalation,
inhalation toxicology/pulmonary toxicology,inhalation
injury,
innate immunity,
Innate immunity,innate immunity
integrin,integrins
integrin ? M,integrins
integrin alpha v beta 5,integrins
integrin beta 4,integrins
integrin? 2,integrins
Integrins,integrins
integrins,
intensive care,
Intensive care unit,
interaction,
Interaction,interaction
intercellular adhesion molecule-1,ICAM-1
intercellular communication networks,
interferon-gamma,
interleukin-1 beta,
Interleukin-17,
interleukin-6,
interleukin-6 (IL-6),interleukin-6
interleukin-8,
intermedin (IMD),
intersectin-1s,
Intestinal barrier,
intestinal injury,
intestinal ischemia,
intracellular sphingosine-1-phosphate,S1P/S1PR1/S1PR2/S1PR3
intravital microscopy,
IQGAP1,
iron chelators,
Iron complexes,
ischemia,ischemia/reperfusion
ischemia reperfusion injury,ischemia/reperfusion
ischemia/reperfusion,ischemia/reperfusion
Ischemia/reperfusion,ischemia/reperfusion
Ischemia-reperfusion,ischemia/reperfusion
ischemia-reperfusion injury,ischemia/reperfusion
ISM1,
isoflurane,
isolated perfused lungs,
Isoorientin,
Isopropyl 3-(3,
ITGA5,
JAK2,
JAK-STAT signaling pathway,
Janus Kinase 2,JAK2
Janus kinase-2,JAK2
Jingfang granules,
JNK,
JNK phosphorylation,JNK
JNK signalling,JNK
Junction protein,
junctional complexes,
Kaempferol,
Kawasaki disease shock syndrome,
KCa3.1,
Keap1,
Kidney,
kinases,
kindlin-2,
Kir2.1,
KLF7,
KRIT1,
Kruppel-like factor 2,KLF2
laboratory animals,
lamellipodia,
large conductance K+ channels,
large conductance potassium channels,
LBP,
LDHA,
Lentiviral vector,
leukocyte adhesion,
leukocyte antibodies,
leukocytes,
LIF,
Linagliptin,
LINC00839,
lipid mediator,
lipid signaling,
Lipids,
lipocalin-type prostaglandin D synthase,
lipopolysaccharide,LPS
Lipopolysaccharide,LPS
lipopolysaccharide (LPS),LPS
Lipopolysaccharide (LPS),LPS
lipopolysaccharide-induced lung injury,LPS; ALI/ARDS
Lipopolysaccharides,LPS
lipopolysaccharides,LPS
Lipopolysaccharides (LPS),LPS
lipoprotein,
liposome,
Liposomes,liposome
lipoxin A4,
Lipoxin A4,lipoxin A4
LipoxinA4,lipoxin A4
lipoxins,
lncRNA,
LncRNA H19,
LncRNA MALAT1,
lncRNA NORAD,
lncRNA OIP5-AS1,
lncRNA THRIL,
Local anesthetics,
long myosin light chain kinase,
Long non-coding RNA cardiac hypertrophy-related factor (lncRNA CHRF),
LPS,
LPS-induced acute lung injury,LPS; ALI/ARDS
LRR- and pyrin domain-containing protein 3 inflammasome,
LTB4 receptors,
L-type voltage-gated Ca2+ channels,
Lung,lung
lung,
lung adenocarcinoma transcript 1,
lung barrier function,
Lung cancer,lung cancer
lung cancer,
lung capillaries,
Lung development,
lung disease,
Lung disease,lung disease
Lung edema,lung edema
lung edema,
lung endothelial cells,ECs/HPMECs/HUVECs/MPVECs
lung endothelial permeability,permeability
lung endothelium,ECs/HPMECs/HUVECs/MPVECs
lung epithelial cells,
Lung fibrosis,
lung function,
Lung function,lung function
Lung imaging,
lung inflammation,
Lung inflammation,lung inflammation
lung inflammatory injury,
Lung injury,ALI/ARDS
lung injury,ALI/ARDS
Lung Injury,ALI/ARDS
lung ischemia reperfusion injury,ischemia/reperfusion
lung ischemia-reperfusion,ischemia/reperfusion
Lung mechanics,
lung microvascular endothelial cells,ECs/HPMECs/HUVECs/MPVECs
Lung microvascular endothelial cells,ECs/HPMECs/HUVECs/MPVECs
lung oedema,
lung permeability,permeability
Lung protein permeability,permeability
Lung recovery,
lung resection,
lung targeting,
Lung targeting,lung targeting
lung transplant,lung transplantation
lung transplantation,
lung vascular endothelium,ECs/HPMECs/HUVECs/MPVECs
lung vascular injury,
Lung vascular permeability,permeability
lung vascular permeability,permeability
Luteolin,
Lycium barbarum polysaccharide,
lysophosphatidic acid,
lysophosphatidylcholine,
lysophospholipid,
Lysosome,
M2 macrophages,
macrophage,
Macrophage depletion,
macrophage polarization,
Macrophages,macrophage
macrophages,macrophage
malaria,
Malaria,malaria
MALAT1,
mammalian TOR (mTOR)/signal transducer and activator of transcription 3 (STAT-3) pathway,mTOR/STAT3 pathway
MAP kinase,MAPK
MAP Kinase Signaling System,MAPK
MAP kinases,MAPK
MAPK,
MAPKinase,MAPK
mapks,MAPK
MAPKs,MAPK
margination,
Mas receptor,
mast cell activation,
matory responses,
Matrigel,
matrix metalloproteinase,MMP/MMP3/MMP9
Matrix metalloproteinase 9,MMP/MMP3/MMP9
MCP-1,
MCTR1,
mechanical forces,
mechanical stress,
Mechanical ventilation,mechanical ventilation
mechanical ventilation,
mechanism,
mechanisms,mechanism
Mechanisms,mechanism
melatonin,
Membrane dynamics,
meningitis,
MERS-CoV,
Mesenchymal stem cell,mesenchymal stem cell
mesenchymal stem cell,
mesenchymal stem cell (MSC),mesenchymal stem cell
mesenchymal stem cells,mesenchymal stem cell
Mesenchymal stem cells,mesenchymal stem cell
Mesenchymal Stem Cells (MSCs),mesenchymal stem cell
Mesenchymal stem cells (MSCs),mesenchymal stem cell
Mesenchymal stem cells microvesicles,
mesenchymal stem/stromal cells,mesenchymal stem cell
mesenchymal stromal cells,mesenchymal stem cell
mesenteric lymph,
metabolic syndrome,
metabolism,
Metabolism,metabolism
metalloproteinase,
Metastasis-associated lung adenocarcinoma transcript-1,MALAT1
metformin,
methylation,
methylprednisolone,
Mg supplementation,
MG53,
mice.,mouse
microcirculation,
microfluidics,
microparticles,
MicroRNA,miRNA
microRNA,miRNA
MicroRNA-125b-5p,
microRNA-150-5p,
microRNA-374a-5p,
microRNA-877-5p,
microRNA-92a,miR-92a
microRNAs,miRNA
micro-RNAs,miRNA
microsphere,
microthrombogenesis,
Microtubule,microtubule
microtubule,
microtubules,microtubule
Microtubules,microtubule
microvascular barrier,
microvascular endothelial cells,ECs/HPMECs/HUVECs/MPVECs
Microvascular endothelium,ECs/HPMECs/HUVECs/MPVECs
Microvascular permeability,permeability
microvascular permeability,permeability
microvasculature,
microvesicle,
Microvesicles,microvesicle
Midkine,
MIF,
migration,
Migration,migration
mineralocorticoid receptor,
miR-101,
miR-107,
miR-122-5p,
miR-124,
miR-126,
miR-128-3p,
miR-1321,
MiR-142a-5p,
miR-144,
miR-150,
miR-17,
miR-186-5p,
miR-199,
miR-204-3p,
miR-217-5p,
miR-223,
miR-29a,
miR-29b-3p,
miR-30c-5p,
MIR3142HG,
miR-3188,
miR-33 and RIP140,
miR-330-5p,
miR-34a,
MiR-4262,
miR-450b-5p,
miR-483-5p,
miR-490,
miR-642a-5p,
miR-92a,
miRNA,
miRNA-181a-5p,
miRNA-21a-3p,
miRNA-451,
Mitochondria,mitochondria
mitochondria,
mitochondrial aldehyde dehydrogenase 2,
Mitochondrial bioenergetics,
Mitochondrial biogenesis,
Mitochondrial DNA,
mitochondrial dysfunction,
mitochondrial fission/fusion,
mitochondrial respiration,
Mitochondrial ROS,ROS
mitochondrial ROS,ROS
mitochondrial targeting,
Mitochondrial transcription factor A,
Mitochondrial transfer,mitochondrial transfer
mitochondrial transfer,
mitochondrial transmembrane potential,
Mitochondrial UPR,
mitochondrial-mediated apoptosis,
mitogen-activated protein kinase,MAPK
Mitogen-activated protein kinase signaling pathways,MAPK
mitogen-activated protein kinases,MAPK
mitogen-activated protein kinases (MAPKs),MAPK
mitophagy,
MitoQ,
MJ33,
MK2,
MK571,
MLCK,
MLKL,
MMP inhibitor,MMP/MMP3/MMP9
MMP1,
MMP3,MMP/MMP3/MMP9
MMP9,MMP/MMP3/MMP9
MMP-9,MMP/MMP3/MMP9
molecular biology,
molecular mechanism,
Molecular pathology,
monocyte,
Monocyte adhesion,
Monocytes,monocyte
morphology,
morphometry,
mouse,
MPO,
MPVEC cells,ECs/HPMECs/HUVECs/MPVECs
MPVECs,ECs/HPMECs/HUVECs/MPVECs
MRP4,
MRSA,
mtDNA repair,
mTOR,
multi-organ dysfunction syndrome (MODS),
multiple organ failure,
Murine model,
murine models,murine model
mutant Prdx6,
MyD88,
MyD88 acetylation,
myeloperoxidase,MPO
MYLK,
myosin,
myosin light chain kinase (MLCK),MLCK
Na+,
NAD(+),
NAD(P)H: quinine oxidoreductase-1,
NADPH oxidase,NOX/NOX1/NOX2/NOX4
NADPH oxidase (NOX),NOX/NOX1/NOX2/NOX4
NADPH oxidase isoform 2 (NOX2),NOX/NOX1/NOX2/NOX4
nanocarrier,
nanomedicine,
Nanomedicine,nanomedicine
Nanoparticles,nanoparticles
nanoparticles,
nanostructured lipid carriers,nanostructured lipid carrier
nanotechnology,
natriuretic peptides,natriuretic peptide
NcRNAs,non-coding RNA
necroptosis,
Necroptosis,necroptosis
necrosis,
neferine,
NE-kappa B,
neonatal pulmonary disease,
neovascularization,
Neovascularization,neovascularization
NETosis,
NETs,neutrophil extracellular traps
network formation,
Neuraminidase,
neutrophil,
Neutrophil,neutrophil
neutrophil adhesion,
Neutrophil adhesion,neutrophil adhesion
neutrophil extracellular trap (NET),neutrophil extracellular traps
neutrophil extracellular traps,
neutrophil migration,
neutrophil recruitment,
neutrophil transendothelial migration,
neutrophil-derived mediators,
Neutrophil-endothelium adhesion,
Neutrophils,neutrophils
neutrophils,
new anti-CitH3 antibody,
NF kappa B Signaling,NF-kappa B
NF-?B,NF-kappa B
NF-?B signaling pathway,NF-kappa B
NF-kappa B,
NF-kappa b,NF-kappa B
NF-kappa B p65,NF-kappa B
NF-kappa B P65,NF-kappa B
NF-kappa B pathway,NF-kappa B
NF-KB,NF-kappa B
NF-KB activation,NF-kappa B
NF-KB pathway,NF-kappa B
niacinamide,
Nicotinamide adenine dinucleotide phosphate oxidase 4,
nicotinamide phosphoribosyltransferase,
Nifedipine,
Nitration,nitration
nitration,
nitrative stress,
nitric oxide,NO
Nitric oxide,NO
Nitric oxide (NO),NO
nitric oxide synthase,
nitric oxide synthase 2,
Nitrite,
nitrogen mustard,
NLRP3,
NLRP3 inflammasome,
NMDA receptor,
NO,
NOD-,
noncanonical TERT,
non-coding RNA,
non-human primate,
Non-muscle myosin heavy chain IIA,
Non-muscle myosin IIA,
Non-muscle myosin light chain kinase,
non-selective cation channel,
nonviral vector,
Notch pathway,
novel coronavirus diseases (or COVID-19),COVID-19/SARS-CoV-2/Coronavirus
NOX enzymes,NOX/NOX1/NOX2/NOX4
NOX1,NOX/NOX1/NOX2/NOX4
NOX2,NOX/NOX1/NOX2/NOX4
NOX2 inhibition,NOX/NOX1/NOX2/NOX4
Nox4,NOX/NOX1/NOX2/NOX4
NOX4,NOX/NOX1/NOX2/NOX4
Nrf(2),Nrf2
Nrf2,
NRF2,Nrf2
NS1619,
nuclear factor (NF)-kB p65,NF-kappa B
nuclear factor erythroid 2-related factor 2,Nrf2
Nuclear factor -kappa B (NF,NF-kappa B
Nuclear factor-kappa B,NF-kappa B
nuclear factor-kappa B,NF-kappa B
nuclear factor-kappa B (NF-kappa B),NF-kappa B
nuclear factor-kappa B pathway,NF-kappa B
nuclear factor-kappaB,NF-kappa B
nuclear translocation,
nucleocapsid,
Nur77,
Obesity,obesity
obesity,
Occludin,
ODSH,
oedema,
Ogg1 depletion,
Omentin-1,
or acute respiratory distress syndrome,ALI/ARDS
Orai 1,
Organ injury,
Organ interaction,
organ protection,
Oridonin,oridonin
oridonin,
osteopontin,
Outcome,
oxidant injury,
oxidant stress,oxidative stress
oxidation,
oxidative burst,
Oxidative damage,
Oxidative Stress,oxidative stress
Oxidative stress,oxidative stress
oxidative stress,
Oxidized low-density lipoprotein,
oxidized phospholipids,
OxPAPC,
oxygen oscillations,
oxygen-glucose deprivation/oxygen-glucose restoration,
P aeruginosa,Pseudomonas aeruginosa
P- selectin,
p190RhoGAP,
p22phox,
p23,
P2Y12 inhibitors,
P2Y12 receptor,
p38,MAPK
P38,MAPK
p38 MAP kinase,MAPK
p38 MAPK,MAPK
p38 MAPK signaling pathway,MAPK
p38 mitogen-activated protein kinase,MAPK
P38MAPK,MAPK
p38MAPK,MAPK
p47phox,
P53,
p53 induction,P53
P53 pathway,P53
P73,
PAI-1,plasminogen activator inhibitor 1
PAK1/AKT pathway,
PAMPs,Pathogen-associated molecular patterns (PAMPs)
PAR,
paracellular permeability,
Paracrine,
Paracrine effects,
Paraquat,
paraquat,
PARK7,
parthanatos,
Particulate matter,
pathobiology,
Pathogen-associated molecular patterns (PAMPs),
pathology,
Pathology Section,
Pathophysiologic feature,
pathophysiology,
pathway analysis,
paxillin,
PBEF/NAMPT,
p-Catenin,
p-Coumaric acid,
PCTR1,
PDE4B,
PEAR1,
PECAM-1,
pediatrics,
PEEP,
PEL12,
Pentraxin 3,
perivascular edema,
Permeability,permeability
permeability,
Permeability barrier,
Peroxisome proliferator-activated receptor gamma,
PFKFB3,
PGC-1 alpha mitochondria biogenesis,
Pharmacokinetics,
phorbol myristate,
phosphatidic acid signaling,
phosphatidylinositol 3-kinase,PI3K
phosphodiesterase,
phosphodiesterase inhibitor,
Phospholipase D2,
phospholipase D2 (PLD2),Phospholipase D2
phospholipid scramblase 4 (PLSCR4),
phospholipidomics,
phospholipids,
phosphorylation,
phosphotyrosine signaling,
Phytochemicals,
PI3K,
PI3K p110 alpha,PI3K
PI3K/Akt,PI3K/Akt pathway
PI3K/Akt pathway,PI3K/Akt pathway
PI3K/Akt signaling pathway,PI3K/Akt pathway
PI3K/Akt/eNOS,
PI3K/AKT/mTOR pathway,
PIAS1,
Piezo1,
PIM,
PIM1,
PI-PLC,
PKA,
PKC alpha,
PKC inhibitor,
PKC pathway,
PLA(2)G5,
Plasma,
plasma,
plasminogen activator inhibitor 1,
plasminogen activator inhibitor-1,plasminogen activator inhibitor 1
Plasmodium,
platelet,
Platelet activating factor,
platelet-endothelial cell adhesion molecule,
Platelets,platelet
platelets,platelet
plexin C1,
PMN,
PMN extravasation,
PMVEC,ECs/HPMECs/HUVECs/MPVECs
PMVECs,ECs/HPMECs/HUVECs/MPVECs
pneumococcal pneumonia,
Pneumococcal pneumonia,pneumococcal pneumonia
Pneumocytes,
Pneumolysin,pneumolysin
pneumolysin,
pneumonia,
Pneumonia,pneumonia
poisoning,
polymer micelles,
polymorphism,
polymorphonuclear neutrophil,
Polymorphonuclear neutrophils,polymorphonuclear neutrophil
Polyphyllin I,
porcine reproductive and respiratory syndrome virus (PRRSV),
porous silicon,
Post ARDS pulmonary fibrosis,
Postoperative period,
posttranslational,
Post-translational Modification,
Post-translational modifications,Post-translational Modification
PP2A,Thr protein phosphatase 2A
Pravastatin,
Prdx6 phosphorylation,
pre-B cell colony-enhancing factor,
preconditioning,
preterm neonates,
prevention,
primary graft dysfunction,
primary human lung cells,
priming,
Pristimerin,
PRNCR1,
progenitor cells,
Prognosis,
programmed cell death,
Pro-inflammatory factor,
proinflammatory mediators,
Proliferation,proliferation
proliferation,
promoter,
promoter activity,
propofol,
prostaglandin F-2 alpha (PGF(2 alpha)),
prostanoid EP receptor,
Protective autophagy,
protein C,protein kinase C
Protein kinase C,protein kinase C
protein kinase C,
Protein kinase C-delta,protein kinase C
protein kinase G,
protein processing,
Protein Structure,
protein tyrosine phosphatase non-receptor type 14 (PTPN14),
proteome,
proteomics,
P-selectin,
Pseudomonas aeruginosa,
PTEN,
PTP1B,
PTX,
pulmonary,
Pulmonary,pulmonary
pulmonary angiogenesis,
pulmonary arterial hypertension,
pulmonary artery,
pulmonary artery endothelial cells,ECs/HPMECs/HUVECs/MPVECs
Pulmonary barrier dysfunction,
pulmonary biology,
pulmonary capillary,
pulmonary capillary endothelial cells,ECs/HPMECs/HUVECs/MPVECs
pulmonary capillary vessels,pulmonary capillary vessel
pulmonary circulation,
pulmonary disease,
pulmonary EC,ECs/HPMECs/HUVECs/MPVECs
pulmonary edema,
Pulmonary edema,pulmonary edema
pulmonary embolism,
pulmonary endothelial barrier,ECs/HPMECs/HUVECs/MPVECs
Pulmonary endothelial barrier,ECs/HPMECs/HUVECs/MPVECs
pulmonary endothelial cell,ECs/HPMECs/HUVECs/MPVECs
pulmonary endothelial cells,ECs/HPMECs/HUVECs/MPVECs
Pulmonary endothelial cells,ECs/HPMECs/HUVECs/MPVECs
Pulmonary endothelial permeability,permeability
pulmonary endothelial permeability,permeability
Pulmonary endothelium,ECs/HPMECs/HUVECs/MPVECs
pulmonary endothelium,ECs/HPMECs/HUVECs/MPVECs
Pulmonary epithelial cells,pulmonary epithelial cell
pulmonary fibrosis,
Pulmonary fibrosis,pulmonary fibrosis
pulmonary function,
pulmonary hypertension,
Pulmonary hypertension,pulmonary hypertension
pulmonary hypoplasia,
pulmonary inflammation,
Pulmonary inflammation,pulmonary inflammation
pulmonary inflammatory disease,pulmonary inflammation
pulmonary injury,
pulmonary microvascular endothelial cell,ECs/HPMECs/HUVECs/MPVECs
Pulmonary microvascular endothelial cell,ECs/HPMECs/HUVECs/MPVECs
pulmonary microvascular endothelial cells,ECs/HPMECs/HUVECs/MPVECs
Pulmonary microvascular endothelial cells,ECs/HPMECs/HUVECs/MPVECs
pulmonary microvascular endothelial cells (PMVECs),ECs/HPMECs/HUVECs/MPVECs
Pulmonary microvascular endothelial cells (PMVECs),ECs/HPMECs/HUVECs/MPVECs
Pulmonary microvascular endothelial permeability,permeability
pulmonary microvascular endothelium barrier,
Pulmonary microvascular injury and repair,
Pulmonary microvascular permeability,permeability
pulmonary mierovascular endothelial cells,ECs/HPMECs/HUVECs/MPVECs
Pulmonary pathology,
pulmonary sarcoidosis,
pulmonary smooth muscle,
Pulmonary vascular barrier,
Pulmonary vascular endothelial cell,ECs/HPMECs/HUVECs/MPVECs
Pulmonary vascular endothelial cells,ECs/HPMECs/HUVECs/MPVECs
pulmonary vascular endothelium,ECs/HPMECs/HUVECs/MPVECs
Pulmonary vascular endothelium-targeting,
pulmonary vascular leak,
Pulmonary vascular permeability,permeability
pulmonary vasculature,
PV-1,
PWV Analysis,
pyroptosis,
Pyroptosis,pyroptosis
qing yin tang,
qPCR,
RAAS,
Rab GTPase,
RAB26 GTPase,
rabeprazole,
Rac1,
Radiation lung injury,radiation-induced lung injury
radiation-induced lung injury,
radiosensitivity,
RAGE,
Raltegravir,
Ramelteon,
Rap1,
rapamycin,
ras-related C3 botulinum toxin substrate 1,Rac1
Rat,rat
rat,
RBC transfusion,
RBM3,
reactive nitrogen species,
Reactive oxygen species,ROS
reactive oxygen species,ROS
Reactive oxygen species (ROS),ROS
reactive oxygen species (ROS),ROS
reactive oxygen species (ROS) genera-,ROS
receptor,
Receptor interacting protein 140 (RIP140),
receptor subtype-specific mechanism,
Receptor-interacting protein 3,RIP3
receptors,
Recombinant Protein Expression,
Recombinant PSGL-1-Ig fusion protein,
recruitment maneuvers,
red blood cells,
Redox Regulation,
Redox-stress,
reduced albumin,
regeneration,
Regeneration,regeneration
regioisomer,
regulatory T-cells,
remifentanil,
Remodeling,
Renal ischemia-reperfusion,ischemia/reperfusion
renin-angiotensin system,
Renin-angiotensin system (RAS),renin-angiotensin system
Repair,repair
repair,
reperfusion,ischemia/reperfusion
resealing,
respiratory disease,
respiratory distress syndrome,
respiratory distress syndrome (adult),"respiratory distress syndrome, adult"
"Respiratory distress syndrome, adult","respiratory distress syndrome, adult"
"Respiratory Distress Syndrome, Adult","respiratory distress syndrome, adult"
"respiratory distress syndrome, adult","respiratory distress syndrome, adult"
respiratory epithelium,
Respiratory infection,respiratory infection
respiratory infection,
respiratory mechanics,
respiratory system,
Respiratory virus,
Retinal arterioles,
Reverse D-4F,
review,
Rhamnocitrin,
rhAPC,
Rho,Rho/RhoA
Rho (Rho GTPase),Rho/RhoA
Rho GTPases,Rho/RhoA
Rho kinase,Rho/RhoA
Rho kinase inhibitor,Rho/RhoA
Rho/ROCK,Rho/ROCK pathway
Rho/ROCK pathway,
RhoA,Rho/RhoA
RhoA/ROCK,RhoA/ROCK signaling pathway
RhoA/ROCK signaling pathway,
rho-Associated Kinases,Rho/RhoA
Rho-associated protein kinase,Rho/RhoA
rhodopsin,
RhoGDI,
Rho-kinase,Rho/RhoA
RIP3,
rivaroxaban,
RNA interference,
RNA-Seq,
Robo4,
ROCK,
ROCK1,
ROCK2,
root extract,
ROS,
ROS accumulation,ROS
ROS signaling,ROS
Rosiglitazone,
Runx1 isoforms,
Ruscogenin,
sACE2,
Salbutamol,
Saquinavir,
SARS virus,COVID-19/SARS-CoV-2/Coronavirus
SARS-COV-2,COVID-19/SARS-CoV-2/Coronavirus
SARS-CoV-2,COVID-19/SARS-CoV-2/Coronavirus
sartans,
SB203580,
sCD40L,
seawater,
secretion,
secretory phospholipase A(2),
Segmental lipopolysaccharide (LPS) challenge,
SELPLG promoter activity,
Sema3A,
Semaglutide,
semaphorin 7A,
Semaphorin 7A,semaphorin 7A
senescence,
Sepsis,sepsis
sepsis,
Sepsis-associated acute lung injury,sepsis; ALI/ARDS
Sepsis-induced acute lung injury,sepsis; ALI/ARDS
sepsis-induced acute lung injury,sepsis; ALI/ARDS
Sepsis-induced ALI,sepsis; ALI/ARDS
Septic acute lung injury,sepsis; ALI/ARDS
Ser,
serine proteases,
SERP1,
SET gene,
Severe acute pancreatitis,severe acute pancreatitis
severe acute pancreatitis,
Severe Acute Respiratory Syndrome,COVID-19/SARS-CoV-2/Coronavirus
Sevoflurane,
S-Glutathionylation of Src,
SH2 domain-containing protein tyrosine phosphatase 2,
shedding,
short interference (si)-RNA,siRNA
shRNA,
sialic acid,
sickle cell disease,
Signal mechanism,
signal transducer and activator of transcription 5,STAT3/STAT5
signal transducer and activator of transcription-3,STAT3/STAT5
Signal transduction,signal transduction
signal transduction,
signaling,
signaling mechanisms,signaling mechanism
Signaling pathway,signaling pathway
signaling pathway,
silencing,
Simvastatin,simvastatin
simvastatin,
simvastatin delivery,
single-cell RNA sequencing,
Single-cell RNA sequencing,single-cell RNA sequencing
single-cell RNA-sequencing,single-cell RNA sequencing
siRNA,siRNA
Sirt1,SIRT1
SIRT1,SIRT1
SIRT1 protein,SIRT1
SIRT3,
Sirtuin,
sitagliptin,
Sivelestat,
Sivelestat sodium (SIV),Sivelestat
skeletal rearrangement,
SLC-0111,
Slit2,
SMAD2,
SMAD7,
Small extracellular vesicles,
small interfering RNA,siRNA
small RNA,
Smoke inhalation,smoke inhalation
smoke inhalation,
SND,
SNHG3,
S-nitrosoalbumin,
S-nitrosylation,
SOCE,store-operated calcium entry
SOCs,
soluble adenylate cyclase,
soluble adenylyl cyclase,soluble adenylate cyclase
Soluble cluster of differentiation 74,
soluble fractalkine,
Sonic hedgehog,
Sox9,
Sp1,
sphingolipids,
sphingomyelin synthase,
S1P,S1P/S1PR1/S1PR2/S1PR3
S1P lyase,S1P/S1PR1/S1PR2/S1PR3
S1P receptors,S1P/S1PR1/S1PR2/S1PR3
S1p receptors,S1P/S1PR1/S1PR2/S1PR3
S1PR1,S1P/S1PR1/S1PR2/S1PR3
S1pr1,S1P/S1PR1/S1PR2/S1PR3
Sphingosine 1-phosphate,S1P/S1PR1/S1PR2/S1PR3
sphingosine 1-phosphate,S1P/S1PR1/S1PR2/S1PR3
sphingosine 1-phosphate receptor 1,S1P/S1PR1/S1PR2/S1PR3
sphingosine kinase,
sphingosine kinase 1,
Sphingosine-1-phosphate,S1P/S1PR1/S1PR2/S1PR3
sphingosine-1-phosphate,S1P/S1PR1/S1PR2/S1PR3
sphingosine-1-phosphate lyase,S1P/S1PR1/S1PR2/S1PR3
sphingosine-1-phosphate receptor 2,S1P/S1PR1/S1PR2/S1PR3
sphingosine-1-phosphate receptor-3,S1P/S1PR1/S1PR2/S1PR3
spike protein,
spironolactone and dexamethasone,
sPLA(2)-V,
splicing,
Src,
SRC,Src
Src protein tyrosine kinase,Src
Src signaling,Src
Src/VE-Cadherin pathway,
Src-suppressed C kinase substrate,
SRPK1,
SRT1720,
Stanford type-A acute aortic dissection,
stanniocalcin,
Staphylococcus aureus,
Staphylococcus aureus (S,Staphylococcus aureus
Staphylococcus aureus enterotoxin,Staphylococcus aureus
STAT3,STAT3/STAT5
STAT3 pathway,STAT3/STAT5
STAT3 Transcription Factor,STAT3/STAT5
statins,
Statins,statins
STEAP1,
Steen solution,
Stem cell therapy,
Stem cell transplantation,Stem cell therapy
Stem/progenitor cells,stem/progenitor cell
STING,
store-operated calcium entry,
Stress fibers,
stretch,
stromal interacting molecule 1,
Stromelysin1,MMP/MMP3/MMP9
stromelysin-1,MMP/MMP3/MMP9
SU5416,
sub-phenotypes,
substrate stiffness,
sulfatase 2,
Sulforaphane,
sulfur dioxide,
superinfection,
Superoxide Ion,
Surface charge,
surface modification,
Surfactants,
survival,
survival and homing,
sweet taste,
Syndecan-1,
systemic disease,
Systemic inflammation,
Systemic inflammatory response,
T cells,
T helper cell immune responses,
T1R3,
target genes,
Targeted drug delivery,
targeted drugs,
targeted therapy,
targeting ability,
Targeting strategy,
tau,
Technique,
Telocyte,
telocytes,
TEM,
TER,
terbutaline,
tert-butyl hydroperoxide,
tetramethylpyrazine,
Tetramethylpyrazine,
TGF-beta 1,
TGF-beta signaling,
TGFBR3,
therapeutic targets,
therapy,
theta defensin,
thiourea,
Thr protein phosphatase 1,
Thr protein phosphatase 2A,
thrombin,
Thrombin,
thrombomodulin,
thrombosis,
thromboxane,
ticagrelor,
Tie1,Tie1/Tie2
Tie-1,Tie1/Tie2
Tie2,Tie1/Tie2
Tie-2,Tie1/Tie2
tight junction,
Tight junction,tight junction
tight junction protein,tight junction
Tight junction protein,tight junction
Tight junction proteins,tight junction
tight junction proteins,tight junction
Tight junctions,tight junction
tight junctions,tight junction
tight junctions (TJs),tight junction
TIMP-1,
tissue damage,
tissue factor,
tissue factor pathway inhibitor,
tissue plasminogen activator,
TLR2,TLR/TLR2/TLR4
TLR4,TLR/TLR2/TLR4
TMP269,
TNF,TNF/TNF-alpha/TNFR1
TNF-a,TNF/TNF-alpha/TNFR1
TNFAIP3,
TNF-alpha,TNF/TNF-alpha/TNFR1
TNFR1,TNF/TNF-alpha/TNFR1
tobacco,
Tocilizumab,tocilizumab
tocilizumab,
tolerance,
Toll -like receptor,TLR/TLR2/TLR4
toll like receptor 4,TLR/TLR2/TLR4
Toll-like receptor 4 (TLR4),TLR/TLR2/TLR4
Toll-like receptors,TLR/TLR2/TLR4
Topoisomerase II alpha,
TRAF6-mediated pathway,
TRALI,transfusion; ALI/ARDS
Tranilast,
transcript regulation,
transcription factor,
transcription factors,transcription factor
transcriptional regulation,
transcriptional repression,
transcriptome,
transcriptome analysis,transcriptome
transcriptomics,
transcriptomics and bioinformatics,
transcytosis,
Transendothelial migration,
transendothelial resistance,
transforming growth factor-beta receptor type 2 (TGF-beta-R2),
Transfusion,transfusion
transfusion,
Transfusion medicine,transfusion
transfusion-related acute lung injury,transfusion; ALI/ARDS
Transfusion-related acute lung injury,transfusion; ALI/ARDS
transfusion-related acute lung injury (TRALI),transfusion; ALI/ARDS
Transient receptor potential vanilloid 4 (TRPV4),
translational outcomes,translational outcome
translational research,
transmigration,
Trans-migration,transmigration
Transmission electron microscopy,
transwell co-cultures,
Trauma,trauma
trauma,
Trauma and injury,trauma
trauma/hemorrhagic shock,
treatment,
Treatment,treatment
tripartite motif containing 37,
Tripterygium hypoglaucum,
Trogocytosis,
TRPC,
TRPV4,Transient receptor potential vanilloid 4 (TRPV4)
TSGL-Ig,
TTP-like syndrome,
tubulin,
TUG1,
tumor necrosis factor,TNF/TNF-alpha/TNFR1
tumor necrosis factor a,TNF/TNF-alpha/TNFR1
tumor necrosis factor receptor type I,TNF/TNF-alpha/TNFR1
tumor necrosis factor receptor-1,TNF/TNF-alpha/TNFR1
tumor necrosis factor-alpha,TNF/TNF-alpha/TNFR1
Tumor necrosis factor-alpha,TNF/TNF-alpha/TNFR1
TUNEL assay,
Tunneling nanotubes,tunneling nanotube
Two-hit,
two-hit ALI,
two-hit model,
Txnip,
type 2 alveolar epithelial cells,type 2 alveolar epithelial cell
tyrosine kinase,
ubiquitin E3 ligase,
ubiq-uitination,
Ubiquitin-specific protease 18,
ulinastatin,
Ulinastatin (UTI),ulinastatin
ultrastructure,
Unc-51 like autophagy activating kinase 1,
Unfolded protein response,
unfolded protein response,
Unfractionated heparin,
Urea-correction,
ursodeoxycholic acid,
USA300,
vagal stimulation,
Vascular,vascular
vascular,
Vascular barrier,vascular barrier
vascular barrier,
Vascular barrier dysfunction,
vascular biology,
vascular diseases,vascular disease
Vascular diseases,vascular disease
Vascular endothelial barrier,ECs/HPMECs/HUVECs/MPVECs
Vascular endothelial cadherin,VE-cadherin
vascular endothelial cadherin,VE-cadherin
vascular endothelial cell,ECs/HPMECs/HUVECs/MPVECs
vascular endothelial cell (VEC),ECs/HPMECs/HUVECs/MPVECs
Vascular endothelial cells,ECs/HPMECs/HUVECs/MPVECs
vascular endothelial cells,ECs/HPMECs/HUVECs/MPVECs
Vascular endothelial dysfunction,
vascular endothelial glycocalyx,endothelial glycocalyx (EG)
Vascular endothelial growth factor,VEGF/VEGFA
Vascular endothelial growth factor (VEGF),VEGF/VEGFA
vascular endothelial growth factor (VEGF),VEGF/VEGFA
Vascular endothelial growth factor a (VEGFa),VEGF/VEGFA
vascular endothelial-cadherin,VE-cadherin
vascular endothelium,ECs/HPMECs/HUVECs/MPVECs
Vascular endothelium,ECs/HPMECs/HUVECs/MPVECs
Vascular inflammation,vascular inflammation
vascular inflammation,
Vascular injury,
vascular integrity,
Vascular integrity,vascular integrity
vascular leak,vascular leakage
Vascular leak,vascular leakage
vascular leakage,
Vascular leakage,vascular leakage
vascular microthrombotic disease (VMTD),
Vascular permeability,permeability
vascular permeability,permeability
Vascular reactivity,
vascular regeneration,
vascular remodeling,
vascular repair,
vascular targeting,
Vasculature,
Vasculotide,
vasoconstriction,
vasodilation,
vasomotion,
vaspin,
VE-cadherin,
VE-Cadherin,VE-cadherin
VEGF,VEGF/VEGFA
VEGFA,VEGF/VEGFA
veno-occlusive disease,
Ventilation-induced lung injury,ventilator-induced lung injury
Ventilator-induced lung injury,ventilator-induced lung injury
ventilator-induced lung injury,
ventilator-induced lung injury (VILI),ventilator-induced lung injury
VE-PTP,
Verdiperstat,
Vessel permeability,
Vessel type,
Viability,
VILI,ventilator-induced lung injury
Viola diffusa,
viral vector,
virus,
von Willebrand factor,
wearability,
whole lung tissue engineering,
Wnt,
wound healing,
wound healing assay,
XBP-1S,
XBP-1U,
XIST,
Xuebijing Injection,
Y-27632,
Yes-associated protein,
zinc finger E-box binding homeobox 1,
ZO-1,zonula occludens 1
zonula occludens 1,
zonula occludens-1 protein,zonula occludens 1
zonulae occludente 1,zonula occludens 1
zymosan,
#NAME?,
